Skip to content

Application of magnesium sulfate injection combined with psoas quadratus block in laparoscopic hysterectomy

Application of magnesium sulfate injection combined with psoas quadratus block in laparoscopic hysterectomy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200055978
Enrollment
Unknown
Registered
2022-01-30
Start date
2022-02-01
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparoscopic hysterectomy

Interventions

B group:Simple ropivacaine quadratus lumborus block
C group:Quadratus lumborum block ropivacaine combined with magnesium sulfate
A group:Physiological saline

Sponsors

Sichuan Ya'an People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 65 years old; 2. Patients undergoing laparoscopic total hysterectomy; 3. ASA class I - III.

Exclusion criteria

Exclusion criteria: 1. Contraindication of nerve block; 2. History of heart disease, liver and kidney disease; 3. Long term use of calcium channel blockers and hypermagnesemia; 4. Those who have mental history, serious hearing and visual impairment or are unable to communicate and visit for other reasons; 5. There were other serious complications, surgical contraindications and distant metastasis of the tumor; 6. The patient and his family refused to participate.

Design outcomes

Primary

MeasureTime frame
VAS score;

Secondary

MeasureTime frame
Hemodynamic;Perioperative analgesia;Postoperative recovery;

Countries

China

Contacts

Public ContactZhou Shuzhi

Sichuan Ya'an People's Hospital

893915648@qq.com+86 18283560691

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026